Assessment of Urine and Serum Exosomes as Biomarkers for the Diagnosis of Bladder Cancer

Farhan Hussein Kalaf; Manal Kamal Rasheed; Mohammed Bassil Ismail

doi:10.54133/ajms.v6i2.758

Authors

Farhan Hussein Kalaf Department of Clinical Biochemistry, College of Medicine, University of Baghdad, Baghdad, Iraq https://orcid.org/0009-0006-0109-8267
Manal Kamal Rasheed Department of Clinical Biochemistry, College of Medicine, University of Baghdad, Baghdad, Iraq
Mohammed Bassil Ismail Department of Urology, College of Medicine, University of Baghdad, Baghdad, Iraq

DOI:

https://doi.org/10.54133/ajms.v6i2.758

Keywords:

Bladder cancer, Extracellular vesicle, Serum exosome, Urine exosome

Abstract

Background: Bladder cancer (BC) is the most common malignant tumor in the urinary tract and the tenth most common malignancy worldwide. Exosomes are 40–100 nm-diameter nanovesicles that are either released straight from the plasma membrane during budding or merged with the plasma membrane by multivesicular bodies. Objectives: To assess the proportion of serum and urinary Exosome levels in urinary bladder cancer patients, as well as their impact on the disease. Methods: From January 2023 to June 2023, a total of 45 samples of blood and urine were collected from individuals diagnosed with bladder cancer at the Ghazi Hariri Hospital for Specialized Surgery. They included 45 male and female patients, varying in age, as well as 45 healthy controls. The samples were analyzed for exosome levels using the ELISA method. Results: The mean serum and urine exosome levels in the patients' group (14.18 and 20.04) were significantly higher than in the control group (8.21 and 8.94), respectively. Serum exosomes exhibited a significant positive and moderate correlation with urine exosome levels. Conclusions: Serum and urine levels of exosomes can be used as biomarkers to detect bladder cancer, and the urine level seems to be preferential.

Downloads

Download data is not yet available.

References

Afonso J, Gonçalves C, Costa M, Ferreira D, Santos L, Longatto-Filho A, Baltazar F. Glucose metabolism reprogramming in bladder cancer: hexokinase 2 (HK2) as prognostic biomarker and target for bladder cancer therapy. Cancer. 2023;15(3):982. doi: 10.3390/cancers15030982. DOI: https://doi.org/10.3390/cancers15030982

Saginala K, Barsouk A, Aluru JS, Rawla P, Padala SA, Barsouk A. Epidemiology of bladder cancer. Med Sci. 2020;8(1):15. doi: 10.3390/medsci8010015.

Richters A, Aben KK, Kiemeney LA. The global burden of urinary bladder cancer: an update. World J Urol. 2020;38:1895-904. doi: 10.1007/s00345-019-02984-4. DOI: https://doi.org/10.1007/s00345-019-02984-4

Zhu S, Yu W, Yang X, Wu C, Cheng F. Traditional classification and novel subtyping systems for bladder cancer. Front Oncol. 2020;10:102. doi: 10.3389/fonc.2020.00102. DOI: https://doi.org/10.3389/fonc.2020.00102

Saginala K, Barsouk A, Aluru JS, Rawla P, Padala SA, Barsouk A. Epidemiology of bladder cancer. Med Sci. 2020;8(1):15. doi: 10.3390/medsci8010015. DOI: https://doi.org/10.3390/medsci8010015

Lenis AT, Lec PM, Chamie K. Bladder cancer: a review. JAMA. 2020;324(19):1980-1991. doi: 10.3390/medsci8010015. DOI: https://doi.org/10.1001/jama.2020.17598

Wong VK, Ganeshan D, Jensen CT, Devine CE. Imaging and management of bladder cancer. Cancers. 2021;13(6):1396. doi: 10.3390/cancers13061396. DOI: https://doi.org/10.3390/cancers13061396

Ng K, Stenzl A, Sharma A, Vasdev N. Urinary biomarkers in bladder cancer: A review of the current landscape and future directions. Urol Oncol. 2021;39(1):41-51. doi: 10.1016/j.urolonc.2020.08.016. DOI: https://doi.org/10.1016/j.urolonc.2020.08.016

Liang H, Yang Q, Zhang Y, Sun H, Fu Q, Diao T, et al. Development and validation of a predictive model for the diagnosis of bladder tumors using narrow band imaging. J Cancer Res Clin Oncol. 2023;149(17):15867-15877. doi: 10.1007/s00432-023-05355-0. DOI: https://doi.org/10.1007/s00432-023-05355-0

Shrivastava SR, Shrivastava PS. Strengthening rural medical education in the undergraduate training period. Med J Babylon. 2021;18(4):277. doi: 10.4103/mjbl.mjbl_13_22. DOI: https://doi.org/10.4103/MJBL.MJBL_13_22

Elsharkawi F, Elsabah M, Shabayek M, Khaled H. Urine and serum exosomes as novel biomarkers in detection of bladder cancer. Asian Pac J Cancer Prevent. 2019;20(7):2219. doi: 10.31557/apjcp.2019.20.7.2219.

Roy S, Das A, Jahan N, Chatterjee N. Dynamicity of exosomes as immuno-oncological biomarkers in secondary metastasis and cancer therapy. Authorea Preprints. 2020. doi: 10.22541/au.159225412.23207274. DOI: https://doi.org/10.22541/au.159225412.23207274

Lee N, Canagasingham A, Bajaj M, Shanmugasundaram R, Hutton A, Bucci J, et al. Urine exosomes as biomarkers in bladder cancer diagnosis and prognosis: From functional roles to clinical significance. Front Oncol. 2022;12:1019391. doi: 10.3389/fonc.2022.1019391.

Tatischeff I. Current search through liquid biopsy of effective biomarkers for early cancer diagnosis into the rich cargoes of extracellular vesicles. Int J Mol Sci. 2021;22(11):5674. doi: 10.3390/ijms22115674. DOI: https://doi.org/10.3390/ijms22115674

Ibraheem NIA, Ali RH, Ismail MB. Kidney functions and electrolyte disturbance among Iraqi patients with bladder cancer. J Fac Med Bagdad. 2023. doi: 10.32007/jfacmedbagdad.6441985. DOI: https://doi.org/10.32007/jfacmedbagdad.6441985

Abood RA, Abdahmed KA, Mazyed SS. Epidemiology of different types of cancers reported in Basra, Iraq. Sultan Qaboos Univ Med J. 2020;20(3):e295. doi: 10.18295/squmj.2020.20.03.008. DOI: https://doi.org/10.18295/squmj.2020.20.03.008

Hadji M, Rashidian H, Marzban M, Naghibzadeh-Tahami A, Gholipour M, Mohebbi E, et al. Opium use and risk of bladder cancer: a multi-centre case-referent study in Iran. Int J Epidemiol. 2022;51(3):830-838. doi: 10.1093/ije/dyac031. DOI: https://doi.org/10.1093/ije/dyac031

Janković S, Radosavljević V. Risk factors for bladder cancer. Tumorigenesis. 2007;93(1):4-12. doi: 10.1177/030089160709300102. DOI: https://doi.org/10.1177/030089160709300102

Abdolahinia Z, Pakmanesh H, Mirzaee M, Bazrafshan A, Bafti MS, Shahesmaeili A. Opium and cigarette smoking are independently associated with bladder cancer: the findings of a matched case-control study. Asian Pac J Cancer Prevent. 202;22(10):3385. doi: 10.31557/apjcp.2021.22.10.3385. DOI: https://doi.org/10.31557/APJCP.2021.22.10.3385

Tenchov R, Sasso JM, Wang X, Liaw WS, Chen CA, Zhou QA. Exosomes─ nature’s lipid nanoparticles, a rising star in drug delivery and diagnostics. ACS Nano. 2022;16(11):17802-17846. doi: 10.1021/acsnano.2c08774. DOI: https://doi.org/10.1021/acsnano.2c08774

Elsharkawi F, Elsabah M, Shabayek M, Khaled H. Urine and serum exosomes as novel biomarkers in detection of bladder cancer. Asian Pac J Cancer Prevent. 2019;20(7):2219. doi: 10.31557/apjcp.2019.20.7.2219. DOI: https://doi.org/10.31557/APJCP.2019.20.7.2219

Lee N, Canagasingham A, Bajaj M, Shanmugasundaram R, Hutton A, Bucci J, et al. Urine exosomes as biomarkers in bladder cancer diagnosis and prognosis: From functional roles to clinical significance. Front Oncol. 2022;12:1019391. doi: 10.3389/fonc.2022.1019391. DOI: https://doi.org/10.3389/fonc.2022.1019391